SCHEMBL22984077

SCHEMBL22984077

CC(=O)NCCCCCCCCCCCC(N)=O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.73
MAPK1 P28482 1/20 0.73
HIF1A Q16665 1/20 0.73
ADRA1A P35348 1/20 0.69
PAOX Q6QHF9 4/20 0.65
PRMT1 Q99873 1/20 0.45
TSHR P16473 1/20 0.43
CASP2 P42575 1/20 0.42
EPHX1 P07099 4/20 0.41
ALDH1A1 P00352 1/20 0.41
NAMPT P43490 1/20 0.41
FOLH1 Q04609 1/20 0.41
MEN1 O00255 1/20 0.41
FAAH O00519 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
SOAT1 P35610 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5200627 1.00 KDM4E (0.73) KDM4EMAPK1HIF1AADRA1APAOX
SCHEMBL608623 1.00 KDM4E (0.73) KDM4EMAPK1HIF1AADRA1APAOX
SCHEMBL25065006 0.98 KDM4E (0.68) KDM4EMAPK1HIF1AADRA1APAOX
SCHEMBL1525045 0.91 KDM4E (0.64) KDM4EMAPK1HIF1AADRA1APAOX
Hexamethylenebisacetamide SCHEMBL9437043 0.88 KDM4E (0.84) KDM4EMAPK1HIF1AADRA1APAOX
Trifluoroacetic Acid SCHEMBL27664340 0.87 ADRA1A (0.59) KDM4EMAPK1HIF1AADRA1APAOX
SCHEMBL14739904 0.85 KDM4E (1.00) KDM4EMAPK1HIF1AADRA1APAOX
SCHEMBL6516953 0.85 KDM4E (1.00) KDM4EMAPK1HIF1AADRA1APAOX
SCHEMBL14740196 0.85 KDM4E (1.00) KDM4EMAPK1HIF1AADRA1APAOX
SCHEMBL1900654 0.85 KDM4E (1.00) KDM4EMAPK1HIF1AADRA1APAOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919926-B2 Compound or salt thereof, natural killer T cell activator, and pharmaceutical composition KEIO UNIVERSITY (JP) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919926-B2 Compound or salt thereof, natural killer T cell activator, and pharmaceutical composition CD4, NFATC1, PBK KDM4E 1239/4885MAPK1 358/4885HIF1A 994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.